Shu Y - Search Results

1

Merkel cell carcinoma of the thigh: case report and review of the literature.

Jiang W, Xu J, Wang R, Wang T, Shu Y, Liu L. Jiang W, et al. Among authors: shu y. Onco Targets Ther. 2019 Jan 11;12:535-540. doi: 10.2147/OTT.S182169. eCollection 2019. Onco Targets Ther. 2019. PMID: 30666132 Free PMC article.

2

Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk.

Xu J, Yin Z, Gao W, Liu L, Wang R, Huang P, Yin Y, Liu P, Yu R, Shu Y. Xu J, et al. Among authors: shu y. Clin Lung Cancer. 2012 Jan;13(1):44-51. doi: 10.1016/j.cllc.2011.06.009. Epub 2011 Aug 2. Clin Lung Cancer. 2012. PMID: 21813335

3

Effect of gefitinib challenge to initial treatment with non-small cell lung cancer.

Chen X, Li W, Hu X, Geng Y, Wang R, Yin Y, Shu Y. Chen X, et al. Among authors: shu y. Biomed Pharmacother. 2011 Dec;65(8):542-6. doi: 10.1016/j.biopha.2011.04.017. Epub 2011 Jun 12. Biomed Pharmacother. 2011. PMID: 21840160 Clinical Trial.

4

[Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].

Liu YQ, Guo RH, Liu LK, Gao W, Zhu CJ, Wei J, Shu YQ. Liu YQ, et al. Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):426-30. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875482 Chinese.

5

[Expression of HER-2 and leptin in gastric cancer and their clinical significance].

Geng YT, Qiu JR, Wang R, Su YT, Shu YQ, Yin YM. Geng YT, et al. Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):764-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22335909 Chinese.

6

Thermal analysis in the rat glioma model during directly multipoint injection hyperthermia incorporating magnetic nanoparticles.

Liu L, Ni F, Zhang J, Wang C, Lu X, Guo Z, Yao S, Shu Y, Xu R. Liu L, et al. Among authors: shu y. J Nanosci Nanotechnol. 2011 Dec;11(12):10333-8. doi: 10.1166/jnn.2011.5010. J Nanosci Nanotechnol. 2011. PMID: 22408906

7

Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.

Xu JL, Hu LM, Huang MD, Zhao W, Yin YM, Hu ZB, Ma HX, Shen HB, Shu YQ. Xu JL, et al. Asian Pac J Cancer Prev. 2012;13(3):851-6. doi: 10.7314/apjcp.2012.13.3.851. Asian Pac J Cancer Prev. 2012. PMID: 22631660 Free article.

8

MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.

Xu JL, Yin ZQ, Huang MD, Wang XF, Gao W, Liu LX, Wang RS, Huang PW, Yin YM, Liu P, Shu YQ. Xu JL, et al. Asian Pac J Cancer Prev. 2012;13(3):901-7. doi: 10.7314/apjcp.2012.13.3.901. Asian Pac J Cancer Prev. 2012. PMID: 22631669 Free article.

9

Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.

Xu JL, Wang ZW, Hu LM, Yin ZQ, Huang MD, Hu ZB, Shen HB, Shu YQ. Xu JL, et al. Asian Pac J Cancer Prev. 2012;13(5):2157-62. doi: 10.7314/apjcp.2012.13.5.2157. Asian Pac J Cancer Prev. 2012. PMID: 22901187 Free article.

10

Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.

Zhao W, Hu L, Xu J, Shen H, Hu Z, Ma H, Shu Y, Shao Y, Yin Y. Zhao W, et al. Among authors: shu y. Cancer Chemother Pharmacol. 2013 May;71(5):1287-95. doi: 10.1007/s00280-013-2127-8. Epub 2013 Mar 12. Cancer Chemother Pharmacol. 2013. PMID: 23479135 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,936 results

Search Page

Filters